About ReGenX
ReGenX is a research and development stage biopharmaceutical company developing novel therapeutics and research tools based on adeno-associated viral vectors, or AAV vectors.
AAV Therapeutics
Therapeutic development with ReGenX novel AAV serotypes is underway for a variety of diseases and unmet medical needs.
Research Tools
ReGenX provides a range of AAV vector products and services for use in research, including ReGenX Novel AAV Vectors such as AAV7, AAV8, AAV9.
Place an Order For ReGenX Novel AAV Vectors